Developing selective PI3K degraders to modulate both kinase and non-kinase functions

Zimo Yang(University of Electronic Science and Technology of China), Yu Rao(Soochow University), Zhihao Ni(Tsinghua University), Qianlong Liu(Center for Life Sciences), Yuna He(Tsinghua University), Yongbo Liu(South China Agricultural University)
Chinese Chemical Letters
February 1, 2024
10.1016/j.cclet.2024.109577
Cited by 12

Related Papers

PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
|Nature|2012|488
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270